Related references
Note: Only part of the references are listed.Androgen Receptor Immunohistochemical Expression in Undifferentiated/Dedifferentiated Endometrial Carcinoma
Jin Cao et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2022)
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer
Beryl L. Manning-Geist et al.
GYNECOLOGIC ONCOLOGY (2022)
Signal transduction pathway activity in high-grade serous carcinoma, its precursors and Fallopian tube epithelium
Phyllis van der Ploeg et al.
GYNECOLOGIC ONCOLOGY (2022)
GLI3 and androgen receptor are mutually dependent for their malignancy-promoting activity in ovarian and breast cancer cells
Min Lin et al.
CELLULAR SIGNALLING (2022)
Androgen Receptor Immunohistochemical Expression in Undifferentiated/Dedifferentiated Endometrial Carcinoma
Jin Cao et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2022)
Immunology of HPV-mediated cervical cancer: current understanding
Babban Jee et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2021)
Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: LeveragingLarge-ScaleData to Inform Therapeutic Directions
Denis L. Jardim et al.
ONCOLOGIST (2021)
A review of the effects and molecular mechanisms of dimethylcurcumin (ASC-J9) on androgen receptor-related diseases
Hang Hu et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2021)
Cancer of the corpus uteri: 2021 update
Martin Koskas et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2021)
Biological evaluation of antiproliferative and anti-invasive properties of an androstadiene derivative on human cervical cancer cell lines
Agnes E. Kulmany et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
miR-130a-3p promotes cell proliferation and invasion by targeting estrogen receptor α and androgen receptor in cervical cancer
Qiong Fan et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
TLR4/IL-6/IRF1 signaling regulates androgen receptor expression: A potential therapeutic target to overcome taxol resistance in ovarian cancer
Shang-Lang Huang et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer
Marzieh Ehsani et al.
CANCERS (2021)
Testosterone, sex hormone-binding globulin, insulin-like growth factor-1 and endometrial cancer risk: observational and Mendelian randomization analyses
Amy Mullee et al.
BRITISH JOURNAL OF CANCER (2021)
Androgen/Androgen Receptor Signaling in Ovarian Cancer: Molecular Regulation and Therapeutic Potentials
Wei-Min Chung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration- resistant prostate cancer
Meng-Jen Wu et al.
THERANOSTICS (2021)
Case-control study of endogenous sex steroid hormones and risk of endometrial cancer
Christine M. Friedenreich et al.
CANCER CAUSES & CONTROL (2020)
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers
Gloria Mittica et al.
JOURNAL OF OVARIAN RESEARCH (2020)
Role of the TLR4-androgen receptor axis and genistein in taxol-resistant ovarian cancer cells
Shang-Lang Huang et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma
Ludwig Geistlinger et al.
CANCER RESEARCH (2020)
Targeting theKDM4B-AR-c-Mycaxis promotes sensitivity to androgen receptor-targeted therapy in advanced prostate cancer
Dong-E Tang et al.
JOURNAL OF PATHOLOGY (2020)
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer
Martin H. Voss et al.
BRITISH JOURNAL OF CANCER (2020)
Expression of metalloproteinases MMP-2 and MMP-9 is associated to the presence of androgen receptor in epithelial ovarian tumors
Flavia Morales-Vasquez et al.
JOURNAL OF OVARIAN RESEARCH (2020)
CircRNA_100395 inhibits cell proliferation and metastasis in ovarian cancer via regulating miR-1228/p53/epithelial-mesenchymal transition (EMT) axis
Xian Li et al.
JOURNAL OF CANCER (2020)
Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma
Qiong Gan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2019)
Sex steroid hormone receptor expression in the vaginal wall in cervical cancer survivors after radiotherapy
Alexandra Hofsjo et al.
ACTA ONCOLOGICA (2019)
Clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome
Suzy Scholl et al.
EBIOMEDICINE (2019)
Increase Paclitaxel Sensitivity to Better Suppress Serous Epithelial Ovarian Cancer via Ablating Androgen Receptor/Aryl Hydrocarbon Receptor-ABCG2 Axis
Wei-Min Chung et al.
CANCERS (2019)
p66Shc protein through a redox mechanism enhances the progression of prostate cancer cells towards castration-resistance
Dannah R. Miller et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
The epigenetic factor BORIS (CTCFL) controls the androgen receptor regulatory network in ovarian cancer
Marisol Salgado-Albarran et al.
ONCOGENESIS (2019)
Non-nuclear AR Signaling in Prostate Cancer
Alice Zamagni et al.
FRONTIERS IN CHEMISTRY (2019)
A magic drug target: Androgen receptor
Dan Li et al.
MEDICINAL RESEARCH REVIEWS (2019)
N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway
Yu Yin et al.
MOLECULAR CANCER (2019)
Postmenopausal Androgen Metabolism and Endometrial Cancer Risk in the Women's Health Initiative Observational Study
Kara A. Michels et al.
JNCI CANCER SPECTRUM (2019)
Androgen Receptor Expression in Endometrial Carcinoma
Sara L. Zadeh et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2018)
International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013
Joannie Lortet-Tieulent et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013
Joannie Lortet-Tieulent et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas
Simona Stolnicu et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Androgens and endometrium: New insights and new targets
Ioannis Simitsidellis et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system
Kaijian Ling et al.
JOURNAL OF OVARIAN RESEARCH (2018)
The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications
Haiyan Zhu et al.
ONCOTARGET (2017)
Src promotes castration-recurrent prostate cancer through androgen receptor-dependent canonical and non-canonical transcriptional signatures
Indranil Chattopadhyay et al.
ONCOTARGET (2017)
Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review
Alex K. Mezei et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
The Impact of Androgen Receptor Expression on Endometrial Carcinoma Recurrence and Survival
Zaid Mahdi et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2017)
Androgen receptor gene CAG repeat polymorphism and ovarian cancer risk: A meta-analysis
Yang Deng et al.
BIOSCIENCE TRENDS (2017)
Aandrogen receptor status predicts development of brain metastases in ovarian cancers
Gloria Mittica et al.
ONCOTARGET (2017)
Synchronous Endometrial and Ovarian Cancer in Young Women: Case Report and Review of the Literature
Askin Dogan et al.
ANTICANCER RESEARCH (2017)
Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells
Karla Kohan-Ivani et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival
A. M. Kamal et al.
BRITISH JOURNAL OF CANCER (2016)
Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel
Benjamin C. Thomas et al.
ENDOCRINE-RELATED CANCER (2016)
Association of androgen receptor CAG repeat polymorphism and risk of epithelial ovarian cancer
Tongyu Zhu et al.
GENE (2016)
Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer
Wenjuan Wu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Highly and moderately aggressive mouse ovarian cancer cell lines exhibit differential gene expression
Fengkun Du et al.
TUMOR BIOLOGY (2016)
Androgen receptor as potential therapeutic target in metastatic endometrial cancer
Ingvild Loberg Tangen et al.
ONCOTARGET (2016)
Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors
Sherri Z. Millis et al.
JAMA ONCOLOGY (2016)
Evidence for the Relationship Between Endometriosis and Epithelial Ovarian Cancer
Marcela G. del Carmen
OBSTETRICAL & GYNECOLOGICAL SURVEY (2015)
Sex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival
Jenny-Maria Jonsson et al.
TRANSLATIONAL ONCOLOGY (2015)
Integrative transcriptomics-based identification of cryptic drivers of taxol-resistance genes in ovarian carcinoma cells: Analysis of the androgen receptor
Nian-Kang Sun et al.
ONCOTARGET (2015)
KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1
Mei-Ting Qiu et al.
ONCOTARGET (2015)
Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition
Jennifer Ose et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Expression analysis of BORIS during pluripotent, differentiated, cancerous, and non-cancerous cell states
Sara Soltanian et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2014)
FOXA1 promotes tumor cell proliferation through AR involving the Notch pathway in endometrial cancer
Meiting Qiu et al.
BMC CANCER (2014)
Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver
C. Chang et al.
ONCOGENE (2014)
Androgen Receptor Increases CD133 Expression and Progenitor-Like Population That Associate With Cisplatin Resistance in Endometrial Cancer Cell Line
Lumin Chen et al.
REPRODUCTIVE SCIENCES (2014)
Ligand-independent androgen receptors promote ovarian teratocarcinoma cell growth by stimulating self-renewal of cancer stem/progenitor cells
Wei-Min Chung et al.
STEM CELL RESEARCH (2014)
Prognostic significance of low DICER expression regulated by miR-130a in cervical cancer
L. He et al.
CELL DEATH & DISEASE (2014)
Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response
Nian-Kang Sun et al.
ONCOTARGET (2014)
Combination of Diane-35 and Metformin to Treat Early Endometrial Carcinoma in PCOS Women with Insulin Resistance
Xin Li et al.
JOURNAL OF CANCER (2014)
Src: marker or actor in prostate cancer aggressiveness
Virginie Vlaeminck-Guillem et al.
FRONTIERS IN ONCOLOGY (2014)
New Therapeutic Approach to Suppress Castration-Resistant Prostate Cancer Using ASC-J9 via Targeting Androgen Receptor in Selective Prostate Cells
Kuo-Pao Lai et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Functional and cancer genomics of ASXL family members
M. Katoh
BRITISH JOURNAL OF CANCER (2013)
FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells
Biswajyoti Sahu et al.
CANCER RESEARCH (2013)
KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer Cells
William L. Berry et al.
CANCER RESEARCH (2013)
Metformin targets c-MYC oncogene to prevent prostate cancer
Tunde Akinyeke et al.
CARCINOGENESIS (2013)
CyclinD1, a prominent prognostic marker for endometrial diseases
Shuo Liang et al.
DIAGNOSTIC PATHOLOGY (2013)
Tamoxifen Represses miR-200 MicroRNAs and Promotes Epithelial-to-Mesenchymal Transition by Up-Regulating c-Myc in Endometrial Carcinoma Cell Lines
Jiu-Xu Bai et al.
ENDOCRINOLOGY (2013)
DNA methylation and nucleosome occupancy regulate the cancer germline antigen gene MAGEA11
Smitha R. James et al.
EPIGENETICS (2013)
Neoadjuvant treatment of endometrial cancer using anastrozole: A randomised pilot study
Amudha Thangavelu et al.
GYNECOLOGIC ONCOLOGY (2013)
A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells
Wei Bao et al.
MOLECULAR CANCER (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
Estrogen and androgen receptor expression in surface epithelium and inclusion cyst in the ovary of premenopausal and postmenopausal women
Carmen Mendez et al.
JOURNAL OF OVARIAN RESEARCH (2013)
Androgen Receptor Protein Levels Are Significantly Reduced in Serous Ovarian Carcinomas Compared with Benign or Borderline Disease but Are Not altered by Cancer Stage or Metastatic Progression
Miriam S. Butler et al.
HORMONES & CANCER (2013)
The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer
Ting Gui et al.
CANCER EPIDEMIOLOGY (2012)
Prevention of Invasive Cervical Cancer in the United States: Past, Present, and Future
Christine M. Pierce Campbell et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer
Ahmed Elattar et al.
GYNECOLOGIC ONCOLOGY (2012)
The hinge region in androgen receptor control
Liesbeth Clinckemalie et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
Jessica L. L. Robinson et al.
EMBO JOURNAL (2011)
Ligand-dependent Corepressor Acts as a Novel Androgen Receptor Corepressor, Inhibits Prostate Cancer Growth, and Is Functionally Inactivated by the Src Protein Kinase
Mohammad Asim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Correction: Expression and Function of Androgen Receptor Coactivator p44/Mep50/WDR77 in Ovarian Cancer
Martin Ligr et al.
PLoS One (2011)
Decoding of Lipoprotein-Receptor Interactions: Properties of Ligand Binding Modules Governing Interactions with Apolipoprotein E
Miklos Guttman et al.
BIOCHEMISTRY (2010)
Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes
Hannah P. Yang et al.
CARCINOGENESIS (2010)
Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases
Y. Liu et al.
ONCOGENE (2010)
Androgen-related expression of G-proteins in ovarian cancer
L. A. Sheach et al.
BRITISH JOURNAL OF CANCER (2009)
Genetic Variation in the Androgen Receptor Gene and Endometrial Cancer Risk
Hannah P. Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome
Agnieszka Honorata Ludwig et al.
ENDOCRINE-RELATED CANCER (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Prostate-specific membrane antigen expression is a potential prognostic marker in endometrial adenocarcinoma
Paulette Mhawech-Fauceglia et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Androgen receptor expression in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix
Jean-Christophe Noel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2008)
Epidermal growth factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptor
Suxia Bai et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Androgen receptor and 5 alpha-reductase are expressed in pelvic endometriosis
M. M. Carneiro et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2008)
A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission
Douglas Levine et al.
CANCER (2007)
Androgen receptor (AR) coregulators: A diversity of functions converging on and regulating the AR transcriptional complex
Hannelore V. Heemers et al.
ENDOCRINE REVIEWS (2007)
Female mice haploinsufficient for an inactivated androgen receptor (AR) exhibit age-dependent defects that resemble the AR null phenotype of dysfunctional late follicle development, ovulation, and fertility
K. A. Walters et al.
ENDOCRINOLOGY (2007)
Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer
Joellen M. Schildkraut et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Reciprocal regulation of 5 alpha-dihydrotestosterone, interleukin-6 and interleukin-8 during proliferation of epithelial ovarian carcinoma
Yue Wang et al.
CANCER BIOLOGY & THERAPY (2007)
Endogenous androgens and risk of epithelial ovarian cancer: Results from the European prospective investigation into cancer and nutrition (EPIC)
Sabina Rinaldi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Non-genomic effects of the androgen receptor and vitamin D agonist are involved in suppressing invasive phenotype of prostate cancer cells
L Bonaccorsi et al.
STEROIDS (2006)
Alleles with short CAG and GGN repeats in the androgen receptor gene are associated with benign endometrial cancer
G Rodríguez et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Androgen receptor polymorphisms and endometrial cancer risk
M McGrath et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells *
L Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
NRIP, a novel nuclear receptor interaction protein, enhances the transcriptional activity of nuclear receptors
TC Tsai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
GGC and StuI polymorphism on the androgen receptor gene in endometrial cancer patients
M Sasaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Androgenic induction of growth and differentiation in the rodent uterus involves the modulation of estrogen-regulated genetic pathways
PV Nantermet et al.
ENDOCRINOLOGY (2005)
Molecular targets and anticancer potential of indole-3-carbinol and its derivatives
BB Aggarwal et al.
CELL CYCLE (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Structural and functional consequences of glutamine tract variation in the androgen receptor
G Buchanan et al.
HUMAN MOLECULAR GENETICS (2004)
Molecular mechanisms of androgen receptor-mediated gene regulation: structure-function analysis of the AF-1 domain
IJ McEwan
ENDOCRINE-RELATED CANCER (2004)
Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Involvement of androgen receptor in 17β-estradiol-induced cell proliferation in rat uterus
WH Zhang et al.
BIOLOGY OF REPRODUCTION (2002)
Formation of the androgen receptor transcription complex
YF Shang et al.
MOLECULAR CELL (2002)
Expression of 5α-reductases in human epithelial ovarian cancer:: Its correlation with androgen receptor status
JI Akahira et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer
C Menin et al.
CANCER LETTERS (2001)
Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium
OD Slayden et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Epidemiology of endometrial cancer
DM Purdie et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2001)
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma
T Anttila et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Do androgens have a direct effect on endometrial function? An in vitro study
EM Tuckerman et al.
FERTILITY AND STERILITY (2000)
Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery
EM Rutanen
HUMAN REPRODUCTION (2000)
Share Paper
